BRIACELL THERAPEUTICS CORP. Increase (Decrease) in Accounts Payable, Trade
BRIACELL THERAPEUTICS CORP. (BCTX) reported Increase (Decrease) in Accounts Payable, Trade of $5.30 million for the 9-month period ending 2024-04-30, per its 10-Q filed 2024-06-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2024-06-14
- 2024-04-30: Increase (Decrease) in Accounts Payable, Trade 9 month $5.30M.
- 2023-04-30: Increase (Decrease) in Accounts Payable, Trade 9 month $531.97K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 9 month |
|---|---|
| 2024-04-30 | $5.30M 10-Q · filed 2024-06-14 |
| 2023-04-30 | $531.97K 10-Q · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |